Recent Updates
Recently added Catalysts
ESPR

Esperion to Participate in Upcoming Virtual Investor Conference

Key Takeaway: ANN ARBOR, Mich., July 27, 2021 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR), today announced that Sheldon Koenig, president and chief executive officer of Esperion will participate in the upcoming BTIG Virtual Biotechnology Conference. Event: BTIG Virtual Biotechnology Conferenc

Full Press Release Details

ANN ARBOR, Mich., July 27, 2021 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR), today announced that Sheldon Koenig, president and chief executive officer of Esperion will participate in the upcoming BTIG Virtual Biotechnology Conference.
Event: BTIG Virtual Biotechnology Conference
Date: August 9, 2021
Format: Fireside Chat
Time: 11:30 a.m. ET
Live audio webcasts of these events can be accessed on the investor relations section of the Esperion website at www.esperion.com/investors-media/events-presentations/. Replays of the webcasts will be archived on the Company's website for 90 days following the events.
ESPERION Therapeutics
Last updated: Jul 27, 2021